The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
Peripheral IV cannulation is one of the most frequently performed procedures in clinical care, but also one of the most skill-dependent. However, as more care moves out of the hospital and into non-clinical environments, the gap between patient need and trained nurse availability is growing. In this blog, see how autonomous IV cannulation is emerging as one potential way to help close this gap.
As Battelle's leader for Environmental Safety & Health (ES&H), Reeves has spent decades helping organizations strengthen performance, develop leaders and manage risk. Along the way, he has learned that lasting safety excellence depends on trust, shared responsibility and a genuine commitment to one another's well-being.
Artificial intelligence has already arrived in healthcare - Not as a single breakthrough, but as a presence woven through the clinician's day in applications both approved and informal. In this blog, explore 3 key ways AI is showing up in healthcare, today.
As research on emerging environmental contaminants accelerates, both regulators and industry need clear guidance on exposure limits, mitigation and testing. Read how ITRC (including members from Battelle) is helping states evaluate contaminants, review emerging environmental technologies and establish technical content using a shared scientific foundation.
In a large-scale emergency, the first hour is the most critical and often the most information-starved. Medical remote sensing is beginning to change that. In this blog, see how remote sensing systems can quickly deliver actionable information to first-responders - when every second counts.
SOCOM has built something remarkable: a human performance enterprise that treats the operator and the family as the mission’s most critical asset. The next frontier isn’t more programs. It’s the infrastructure to make what’s already working scale, connect and endure.
Battelle and The NeuroTech Institute (NTI) launched NeuroLife, a non-invasive neurotechnology company developing wearable solutions to support rehabilitation.
For semiconductor manufacturers, the question is no longer whether PFAS will require greater attention—it’s how quickly companies can understand and manage their exposure. This blog explores why PFAS are essential to semiconductor fabrication, how regulatory and environmental pressures are evolving, and how manufacturers can begin planning their path forward.
In today’s pharma and biotech industries, choosing the right R&D partner is a strategic decision that can shape the trajectory of your entire program. Beyond credentials and case studies, the real differentiator lies in how a partner thinks, collaborates, and evolves. Here's four key questions every leader should ask before hiring a R&D partner.
Special Forces operate at peak intensity for decades—but that performance comes with a cumulative physical and psychological cost. Explore how chronic pain, injury, and allostatic load impact long-term readiness, and why early, integrated, whole-system interventions are essential to sustaining performance, extending careers and improving post-service quality of life.
On May 14 and 15, 2026, Battelle co-sponsored "Beyond Forever: Bridging Policy and Industry with PFAS Solutions," convening policymakers and industry experts at Capitol Hill. We sat down with Battelle's Amy Dindal and Jeff Rose to unpack this important conversation about PFAS policy and solutions.
Poor and interrupted sleep is simply a reality of SOF life.That’s why sleep is increasingly recognized within SOF not as a wellness issue, but as a readiness variable that the force must treat. The question is how we apply what the research already tells us, at scale, across the force.
New Approach Methodologies (NAMs) are poised to transform preclinical research and toxicology. Right now there are three interconnected barriers to in vitro NAMs adoption. Moving NAMs into the mainstream will require approaches that tackle all three together.
The United States is racing to secure the critical minerals that power modern life. While much of the focus has been on opening new mines or securing supplies overseas, one of America’s most accessible domestic resources has been hiding in plain sight.
New Approach Methodologies (NAMs) have demonstrated tremendous promise but there are still structural barriers standing in the way of widespread NAMs adoption. Here how to understand those gaps in promise vs. practice.
There is no more difficult conversation in this work than the one that follows suicide. It not about a single loss. It is about ripple effects that extend across families, teams, and communities. It changes families. It stays with teammates. It challenges leaders. And it leaves questions that do not resolve quickly or cleanly.
For years, when we talked about military families within the Special Operations community, the narrative centered on grit. Resilience. Quiet sacrifice. And if this were simply about any one of those, or even all of them together, we would be fine. But it is not.
There's a shift happening in how safety and efficacy are evaluated across drug development, chemicals, and beyond. New Approach Methodologies (NAMs) have matured into working tools.
In a recent conversation with a group of operators, we had a real, unfiltered discussion about brain injury: what they’ve experienced and seen in their teammates, what they’ve pushed through, and what it has cost over time.
For patients managing chronic conditions, the appeal of implantable drug delivery is easy to understand: a device placed once, delivering medication precisely where it's needed, for months or years at a time. It's a compelling vision—and for some patients, it's already a reality. For many others, it remains just out of reach.
We use cookies to personalize content and ads, to provide social media features and to analyze our traffic. We also share information about your use of our site with our social media, advertising and analytics partners. By continuing to browse our
site without changing your settings, you are agreeing to accept all cookies on the site.
